Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

New chairs at SomaLogic, Anjarium

Plus Dechamps becomes CEO at Bioxodes, and updates from Abalos, M2Gen and Orion

October 19, 2022 12:34 AM UTC

AI-based proteomics company SomaLogic Inc. (NASDAQ:SLGC) appointed board member Troy Cox as executive chair, succeeding Chuck Lillis. Cox was president and CEO of Foundation Medicine Inc., before which he was SVP and officer at Genentech Inc. Lillis, who served as chair for three years, will remain on the board. 

Gaurav Shah became chair at  Anjarium Biosciences AG, a non-viral gene therapy company. Shah was founding CEO of Rocket Pharmaceuticals Inc. (NASDAQ:RCKT), an AAV and lentiviral-based gene therapy company, and venture partner at RTW Investments. Anjarium also appointed Douglas Fambrough, former president and CEO of Dicerna Pharmaceuticals Inc., to its board...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article